APA (7th ed.) Citation

Kam, S. C., Shin, Y. S., Kim, D. s., Lee, W. K., Han, D. H., Song, P. H., . . . Kim, T. H. (2026). Efficacy and Safety of Mirabegron and Tamsulosin Combination Therapy Compared to Tamsulosin Monotherapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Results of a Multicenter, Randomized, Double-Blind, Phase III Clinical Trial. World Journal of Men's Health, 44(2), 427. https://doi.org/10.5534/wjmh.250085

Chicago Style (17th ed.) Citation

Kam, Sung Chul, et al. "Efficacy and Safety of Mirabegron and Tamsulosin Combination Therapy Compared to Tamsulosin Monotherapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Results of a Multicenter, Randomized, Double-Blind, Phase III Clinical Trial." World Journal of Men's Health 44, no. 2 (2026): 427. https://doi.org/10.5534/wjmh.250085.

MLA (9th ed.) Citation

Kam, Sung Chul, et al. "Efficacy and Safety of Mirabegron and Tamsulosin Combination Therapy Compared to Tamsulosin Monotherapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Results of a Multicenter, Randomized, Double-Blind, Phase III Clinical Trial." World Journal of Men's Health, vol. 44, no. 2, 2026, p. 427, https://doi.org/10.5534/wjmh.250085.